Ping Du

835 total citations
58 papers, 642 citations indexed

About

Ping Du is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ping Du has authored 58 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Ping Du's work include Lung Cancer Research Studies (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Climate variability and models (4 papers). Ping Du is often cited by papers focused on Lung Cancer Research Studies (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Climate variability and models (4 papers). Ping Du collaborates with scholars based in China, United States and Canada. Ping Du's co-authors include Lihong Liu, Zhuoling An, Robert Massé, Pengfei Li, Ting Hu, Honggang Bi, Xiaohong Han, Yuankai Shi, Mark Buehner and Guoyong Wang and has published in prestigious journals such as The Science of The Total Environment, Journal of Chromatography A and Monthly Weather Review.

In The Last Decade

Ping Du

57 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Du China 15 173 99 99 79 67 58 642
Akira Akira Japan 11 132 0.8× 62 0.6× 42 0.4× 34 0.4× 93 1.4× 111 610
Emerson Liu United States 10 495 2.9× 127 1.3× 30 0.3× 22 0.3× 161 2.4× 16 1.5k
Tadashi Fujita Japan 15 242 1.4× 74 0.7× 175 1.8× 163 2.1× 48 0.7× 100 916
Outi Kummu Finland 16 230 1.3× 54 0.5× 36 0.4× 7 0.1× 162 2.4× 28 1.1k
Jeong‐Eun Lee South Korea 18 889 5.1× 96 1.0× 26 0.3× 18 0.2× 73 1.1× 45 1.3k
Shuaiwei Wang China 14 252 1.5× 99 1.0× 11 0.1× 12 0.2× 57 0.9× 35 756
Nils Hoem Norway 17 202 1.2× 29 0.3× 10 0.1× 85 1.1× 142 2.1× 44 1.0k
Fengju Li China 9 112 0.6× 44 0.4× 28 0.3× 28 0.4× 39 0.6× 20 379
Masaru Uchida Japan 12 171 1.0× 31 0.3× 62 0.6× 113 1.4× 210 3.1× 46 1.1k
G Frick United States 17 438 2.5× 127 1.3× 40 0.4× 35 0.4× 200 3.0× 47 1.1k

Countries citing papers authored by Ping Du

Since Specialization
Citations

This map shows the geographic impact of Ping Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Du more than expected).

Fields of papers citing papers by Ping Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Du. The network helps show where Ping Du may publish in the future.

Co-authorship network of co-authors of Ping Du

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Du. A scholar is included among the top collaborators of Ping Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Du. Ping Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buehner, Mark, Jean‐François Caron, Alain Caya, et al.. (2025). The Modular and Integrated Data Assimilation System at Environment and Climate Change Canada (MIDAS v3.9.1). Geoscientific model development. 18(1). 1–18.
2.
3.
Du, Ping, Wenyan Qin, Yiyi Hu, et al.. (2024). Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trial. Complementary Therapies in Medicine. 82. 103037–103037. 3 indexed citations
4.
Lu, Qingchun, et al.. (2023). Impact of NLRP3 gene polymorphisms (rs10754558 and rs10733113) on HPV infection and cervical cancer in southern Chinese population. Infectious Agents and Cancer. 18(1). 64–64. 3 indexed citations
5.
Riley, Lance A., Xiping Zhang, Collin M. Douglas, et al.. (2022). The skeletal muscle circadian clock regulates titin splicing through RBM20. eLife. 11. 13 indexed citations
6.
7.
Du, Ping, Lingling Xuan, Ting Hu, Zhuoling An, & Lihong Liu. (2022). Serum Eicosanoids Metabolomics Profile in a Mouse Model of Renal Cell Carcinoma: Predicting the Antitumor Efficacy of Anlotinib. Frontiers in Immunology. 13. 824607–824607. 3 indexed citations
8.
9.
Hu, Ting, et al.. (2021). Parallel derivatization strategy for comprehensive profiling of unconjugated and glycine-conjugated bile acids using Ultra-high performance liquid chromatography-tandem mass spectrometry. The Journal of Steroid Biochemistry and Molecular Biology. 214. 105986–105986. 6 indexed citations
10.
Du, Ping, Guoyong Wang, Rui Zhao, Zhuoling An, & Lihong Liu. (2021). Eicosanoid Metabolomic Profile of Remdesivir Treatment in Rat Plasma by High-Performance Liquid Chromatography Mass Spectrometry. Frontiers in Pharmacology. 12. 747450–747450. 10 indexed citations
11.
12.
Li, Pengfei, Susan Hoppmann, Ping Du, et al.. (2017). Pharmacokinetics of Perfluorobutane after Intra-Venous Bolus Injection of Sonazoid in Healthy Chinese Volunteers. Ultrasound in Medicine & Biology. 43(5). 1031–1039. 20 indexed citations
13.
Du, Ping, Hailing Wang, Yiran Mao, et al.. (2016). Ultrasound-guided core needle biopsy in the diagnosis of neuroblastic tumors in children: a retrospective study on 83 cases. Pediatric Surgery International. 33(3). 347–353. 17 indexed citations
14.
Li, Ning, Xiaohong Han, Ping Du, et al.. (2014). Development and validation of a UPLC–MS/MS assay for the quantification of simotinib in human plasma. Analytical and Bioanalytical Chemistry. 406(6). 1799–1805. 6 indexed citations
15.
Du, Ping, Xiaohong Han, Ning Li, et al.. (2014). Development and validation of an ultrafiltration-UPLC-MS/MS method for rapid quantification of unbound docetaxel in human plasma. Journal of Chromatography B. 967. 28–35. 17 indexed citations
16.
Li, Ning, Yuanyuan Song, Ping Du, et al.. (2013). Oral topotecan: Bioavailability, pharmacokinetics and impact of ABCG2 genotyping in Chinese patients with advanced cancers. Biomedicine & Pharmacotherapy. 67(8). 801–806. 7 indexed citations
17.
Zhu, Xiaolin, et al.. (2010). Early diagnosis of small hepatocellular carcinoma in patients with liver cirrhosis using contrast-enhanced ultrasound and contrast-enhanced magnetic resonance. Zhonghua chaosheng yingxiangxue zazhi. 19(8). 688–692. 4 indexed citations
18.
Cao, Guangwen, et al.. (1997). Construction of retroviral vectors to induce a strong expression of human class interferon gene in human hepatocellular carcinoma cellsin vitro. World Journal of Gastroenterology. 3(3). 139–142. 10 indexed citations
19.
Bi, Honggang, Ping Du, & Robert Massé. (1992). Studies on anabolic steroids—8. GC/MS characterization of unusual seco acidic metabolites of oxymetholone in human urine. The Journal of Steroid Biochemistry and Molecular Biology. 42(2). 229–242. 18 indexed citations
20.
Chen, YX, et al.. (1986). [Cytotoxicity of the monoclonal antibody anti-CCT2 and bleomycin A6 conjugate to leukemia cells].. PubMed. 8(4). 272–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akira Akira Breakdown of academic impact, for papers by Emerson Liu Breakdown of academic impact, for papers by Tadashi Fujita Breakdown of academic impact, for papers by Outi Kummu Breakdown of academic impact, for papers by Jeong‐Eun Lee Breakdown of academic impact, for papers by Shuaiwei Wang Breakdown of academic impact, for papers by Nils Hoem Breakdown of academic impact, for papers by Fengju Li Breakdown of academic impact, for papers by Masaru Uchida Breakdown of academic impact, for papers by G Frick
Rankless by CCL
2026